In a significant policy shift, the University of Pennsylvania has announced it will cease performing gender transition surgeries on minors under 19 years of age. This decision comes in response to federal guidelines and reflects a growing trend among institutions reevaluating their practices regarding youth gender transition.
The announcement was made public via an Instagram post by The Daily Penn, the university’s student newspaper, revealing that Penn Medicine, which oversees several hospitals and medical centers associated with the university, will no longer offer these procedures to minors. Dr. Patrick Brennan, Chief Medical Officer at Penn Medicine, emphasized the institution’s commitment to providing comprehensive care while adhering to federal regulations.
This decision aligns with an executive order signed by former President Donald Trump shortly after taking office, which aimed to restrict federal funding for gender transition surgeries for minors. The order explicitly states that the federal government will not support procedures that alter a child’s biological sex, including surgeries and hormone treatments that could have lasting consequences.
Dr. Brennan acknowledged the emotional weight of this decision, stating, “This is a difficult decision that we know impacts patients and families who place their trust in our care teams.” He reassured the community that the institution remains dedicated to offering a supportive environment for LGBTQ+ individuals while complying with legal mandates.
The executive order outlined specific procedures deemed harmful, including the use of puberty blockers and cross-sex hormones. These treatments have been linked to various health risks, raising concerns among medical professionals and parents alike. The American College of Pediatricians has highlighted potential side effects of puberty blockers, which may include osteoporosis, mood disorders, and cognitive impairment. Furthermore, long-term use of cross-sex hormones can increase risks of serious health issues such as heart attacks and certain cancers.
As more states enact laws limiting or banning gender transition procedures for minors, the University of Pennsylvania’s decision reflects a broader movement across the country. Over two dozen states have implemented restrictions due to concerns about the long-term effects on minors, including states like Florida, Texas, and Arkansas.
In light of these developments, the Center for Medicare and Medicaid Services has requested information from hospitals about their protocols for treating children with gender dysphoria. This includes how informed consent is obtained and the role of parental consent in these significant medical decisions.
As discussions around this topic continue to evolve, many parents and guardians are left seeking guidance on the best paths for their children. It’s essential for families to consult with trusted medical professionals and consider the implications of any medical interventions.
The University of Pennsylvania’s policy change serves as a reminder of the ongoing debates surrounding gender identity, medical ethics, and the welfare of minors. As society grapples with these issues, the priority must remain on the health and well-being of children, ensuring they receive care that is both compassionate and evidence-based.
For more information on the health risks associated with gender transition procedures, you can visit the American College of Pediatricians and stay informed about the latest developments in this critical area of healthcare.